Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02495857 · ClinicalTrials.gov registry record · NA
A Study of Hyaluronate Injectable Viscosupplement for Treatment of Osteoarthritis of the Knee
A NA study, sponsored by Actavis.
- Completed
- Registry status
- NA
- Development phase
- 599
- Enrollment target
NCT02495857 is a NA study that has completed, run by Actavis. The registered enrollment target is 599 participants.
The verdict
NCT02495857, a NA study, has completed, sponsored by Actavis.
- COMPLETED
- Registry status
- NA
- Development phase
- 599 participants
- Enrollment target
Study Summary
The study is a prospective, multi-center, randomized, three-arm, parallel group, clinical study to evaluate the superiority of 3 weekly intra-articular (IA) doses of 2 mL of Investigational hyaluronate as compared to placebo injected into the target knee for the treatment of pain in subjects with Osteoarthritis (OA).The safety and effectiveness of the investigational product will also be compared with Euflexxa.
Interventions
- DEVICE Placebo
- DEVICE Hyaluronate Injectable Viscosupplement
- DEVICE Euflexxa IA injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 599 participants |
| Start Date | 2015-08-15 |
| Est. Completion | 2016-12-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02495857
The ClinicalTrials.gov registry entry for NCT02495857 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 599 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Actavis, which has 79 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT02495857 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02495857 about?
NCT02495857 is a clinical study titled "A Study of Hyaluronate Injectable Viscosupplement for Treatment of Osteoarthritis of the Knee". The study is a prospective, multi-center, randomized, three-arm, parallel group, clinical study to evaluate the superiority of 3 weekly intra-articular (IA) doses of 2 mL of Investigational hyaluronate as compared to placebo injected into the target knee for the treatment of pain in subjects with Os...
What is the current status of trial NCT02495857?
This trial is currently completed. It is a NA study. The enrollment target is 599 participants. The study started on 2015-08-15. Estimated completion is 2016-12-05.
What interventions are being tested in trial NCT02495857?
The interventions under investigation include: Placebo (DEVICE), Hyaluronate Injectable Viscosupplement (DEVICE), Euflexxa IA injection (DEVICE).
Who is sponsoring clinical trial NCT02495857?
This trial is sponsored by Actavis, which has 79 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.